...
首页> 外文期刊>Gastroenterology >Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice.
【24h】

Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice.

机译:缺氧诱导因子2α介导小鼠铁缺乏期间肠铁转运蛋白的适应性增加。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND & AIMS: Iron deficiency and iron overload affect over a billion people worldwide. Dietary iron absorption in the small intestine is required for systemic iron homeostasis. Ferroportin (FPN) is the only characterized, mammalian, basolateral iron exporter. Despite the importance of FPN in maintaining iron homeostasis, its in vivo mechanisms of regulation are unclear. METHODS: Systemic iron homeostasis was assessed in mice with intestine-specific disruption of genes encoding the von Hippel-Lindau tumor suppressor protein (Vhl), hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and aryl hydrocarbon nuclear translocator (ARNT). RESULTS: We observed biphasic regulation of Fpn during iron deficiency. Fpn was rapidly induced under conditions of low iron, which required the transcription factor HIF-2alpha. Targeted disruption of HIF-2alpha in the intestine inhibited Fpn induction in mice with low iron, through loss of transcriptional activation. Analysis of the Fpn promoter and in vivo chromatin immunoprecipitation assays demonstrated that HIF-2alpha directly binds to the Fpn promoter and induces its expression, indicating a mechanism of transcriptional regulation of Fpn following changes in systemic levels of iron. During chronic iron deficiency, FPN protein levels also increased, via increased stability through a HIF-2alpha-independent pathway. CONCLUSIONS: In mice, expression of the gene that encodes Fpn and its protein levels are regulated by distinct pathways to provide a rapid and sustained response to acute and chronic iron deficiency. Therapies that target FPN might be developed for patients with iron-related disorders.
机译:背景与目的:铁缺乏症和铁超负荷影响全球超过十亿人。体内铁稳态需要在小肠中吸收铁。 Ferroportin(FPN)是唯一特征性的哺乳动物基底外侧铁出口商。尽管FPN在维持铁稳态中很重要,但其体内调节机制尚不清楚。方法:在小鼠体内,通过肠特异性破坏编码von Hippel-Lindau抑癌蛋白(Vhl),缺氧诱导因子(HIF)-1alpha,HIF-2alpha和芳烃核转运蛋白(ARNT)的基因,评估了系统铁稳态)。结果:我们观察到铁缺乏时Fpn的双相调节。在低铁条件下迅速诱导了Fpn,这需要转录因子HIF-2alpha。肠中HIF-2alpha的靶向破坏通过丢失转录激活抑制了铁含量低的小鼠中的Fpn诱导。对Fpn启动子和体内染色质免疫沉淀分析的分析表明,HIF-2alpha直接与Fpn启动子结合并诱导其表达,表明在体内铁水平变化后Fpn的转录调控机制。在慢性铁缺乏症中,FPN蛋白水平也通过HIF-2alpha依赖性途径提高稳定性而增加。结论:在小鼠中,编码Fpn及其蛋白水平的基因的表达受到不同途径的调节,从而对急性和慢性铁缺乏症提供快速而持续的反应。可能针对患有铁相关疾病的患者开发针对FPN的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号